Intelligence Profile
Research Papers
Research Papers and Clinical Trials
Recent research on testosterone enanthate and testosterone therapy spans several clinical applications, though many studies focus on specific populations with limited sample sizes.
Pediatric and Adolescent Applications
Several studies have examined testosterone use in young patients with developmental concerns. Research has investigated testosterone therapy for boys with constitutional delay of growth and puberty, with one systematic review and meta-analysis synthesizing available evidence from PubMed databases. Another study found that low-dose testosterone treatment improved wellbeing and emotional state in boys with self-limited delayed puberty, though specific sample sizes were not provided in the available abstracts.
Testosterone treatment has also been studied for micropenis in cases of partial androgen insensitivity syndrome, representing a specialized therapeutic application. Additionally, research has examined the relationship between preoperative testosterone administration and surgical complications, specifically urethrocutaneous fistula formation after primary hypospadias repair.
Adult Male Hypogonadism and Body Composition
Clinical research has evaluated testosterone replacement therapy combined with exercise for improving body composition in hypogonadal men, though detailed study parameters are not available from the abstracts reviewed.
Oncology Applications
A completed Phase 3 clinical trial (NCT00965341) investigated testosterone replacement specifically for fatigue in male hypogonadal advanced cancer patients, representing the highest level of evidence available in the clinical trials database. Another completed Phase 2 trial (NCT02286921) examined whether testosterone could abolish negative symptoms and foster objective responses while modulating resistance to enzalutamide, an androgen receptor antagonist used in prostate cancer treatment.
Other Clinical Applications
A Phase 2 trial (NCT04460872) is currently recruiting participants to study locomotor training combined with testosterone for promoting bone and muscle health after spinal cord injury. A completed Phase 2 pharmacokinetic study (NCT02697188) examined oral testosterone ester formulations in hypogonadal men. One trial investigating testosterone during pulmonary rehabilitation in early-stage COPD was withdrawn.
Limitations
The available evidence shows considerable heterogeneity in study populations, dosing regimens, and outcome measures. Many studies appear to involve small sample sizes or specialized patient populations, which may limit the generalizability of findings. Detailed methodology and results are not available from the abstracts provided.
This summary is based on study titles and basic trial information only. Consult with healthcare providers for personalized medical advice regarding testosterone therapy.